24 results
10-Q
2020 Q3
NRIX
Nurix Therapeutics Inc
14 Oct 20
Quarterly report
4:02pm
and we may not realize the expected value from this strategy.
We are subject to anti-corruption laws, as well as export control laws, customs laws … operations are subject to anti-corruption laws, including the Foreign Corrupt Practices Act (the FCPA), the Bribery Act and other anticorruption laws
S-3ASR
EX-1.2
sneghqlin48g
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-1.1
fvjfd
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
10-K
m3i7ikg66x7e wmnrgxy
16 Feb 21
Annual report
4:11pm
S-1
uh7eiraxis6u6scp ut
2 Jul 20
IPO registration
4:04pm